COMMUNIQUÉS West-GlobeNewswire

Merit Medical Systems to Announce First Quarter 2026 Results on April 30, 2026
03/04/2026
SOUTH JORDAN, Utah, April 02, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today that it will release its financial results for the quarter [...]
RxSight, Inc. to Participate in the 25th Annual Needham Virtual Healthcare Conference
02/04/2026
ALISO VIEJO, Calif., April 02, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., today announced plans to participate in the upcoming 25th Annual Needham Virtual Healthcare Conference. Management is scheduled to [...]
Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
02/04/2026
SAN DIEGO, April 02, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)- [...]
Information relative au nombre total des droits de vote et d’actions composant le capital social au 31 mars 2026
02/04/2026
Information relative au nombre total des droits de vote et d’actions composant le capital social au 31 mars 2026 (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) Place de cotation : NYSE [...]
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
02/04/2026
FOSTER CITY, Calif., April 02, 2026 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage oncology company, today announced that it has granted as of April 1, 2026 [...]
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of March 31, 2026
02/04/2026
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of March 31, 2026 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE [...]
Conavi Medical Announces Results from Its Annual General Meeting of Shareholders
02/04/2026
TORONTO, April 02, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI; OTCQB: CNVIF) (“ Conavi Medical ” or the “ Company ”), a commercial stage medical device company focused on designing, manufacturing, and [...]
Minerva Announces Leadership Transition
02/04/2026
Jim O’Connor joins as Chief Business Officer and General Counsel BURLINGTON, Mass., April 02, 2026 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on [...]
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/04/2026
SAN FRANCISCO, April 02, 2026 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and [...]
ApolloMD Announces Exclusive Professional Liability Solution with The Doctors Company
02/04/2026
ATLANTA, April 02, 2026 (GLOBE NEWSWIRE) -- ApolloMD, a physician-led practice management organization that provides administrative, operational, and business support services to physician practices nationwide, [...]
Vericel Announces BARDA Award Valued at up to $197 Million for Procurement and Advanced Development of NexoBrid
02/04/2026
CAMBRIDGE, Mass., April 02, 2026 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, has been awarded a ten-year contract valued at [...]
Get Summer-Season Ready with New Notorious Fitness Training Plans
02/04/2026
Premium Coaching Tiers Maximize Stamina & Physique for Las Vegas Festivals and Day Clubs Las Vegas, Nevada , April 02, 2026 (GLOBE NEWSWIRE) -- As Las Vegas prepares for its world-famous summer entertainment season [...]
MediWound Reports BARDA Contract Award to Vericel for NexoBrid® Valued at up to $197 Million
02/04/2026
MediWound Reports BARDA Contract Award to Vericel for NexoBrid ® Valued at up to $197 Million YAVNE, Israel, April 2, 2026 — MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics [...]
GENFIT : Résultats financiers annuels 2025 et point sur les activités de la Société
02/04/2026
Faits financiers marquants de 2025 : Trésorerie et équivalents de trésorerie s’élevant à 101.1 millions d’euros au 31 décembre 2025 Chiffre d’affaires s’élevant à 65.4 millions d’euros au 31 décembre 2025, dont 43.6 [...]
GENFIT Reports Full-Year 2025 Financial Results and Provides Corporate Update
02/04/2026
2025 financial highlights: Cash and cash equivalents totaled €101.1 million as of December 31, 2025 Revenues amounting to €65.4 million for the period ended December 31, 2025, including €43.6 million in milestones and € [...]
AbbVie IBD Scholarship Program Marks 15 Years: Applications Open for 2026
02/04/2026
Celebrating 15 years of impact, the program supports Canadian students with Crohn’s disease or ulcerative colitis with fifteen $5,000 scholarships in 2026 TORONTO, April 02, 2026 (GLOBE NEWSWIRE) -- Crohn’s and Colitis [...]
Liv Hospital Highlights Hospital-Based Stem Cell Infrastructure During Autism Awareness Month
02/04/2026
LivMedCell’s Ministry of Health-licensed cGMP framework supports physician-led evaluation and multidisciplinary clinical coordination Photo: Liv Hospital Ulus via FL Comms ISTANBUL, April 02, 2026 (GLOBE NEWSWIRE) -- [...]
EssilorLuxottica acquires a stake in Top Charoen, reinforcing its presence in Thailand
02/04/2026
EssilorLuxottica acquires a stake in Top Charoen, reinforcing its presence in Thailand Paris, France and Bangkok, Thailand (2 April 2026) – EssilorLuxottica and Top Charoen today announced that they have closed a [...]
BioCardia Files Request for Meeting With FDA to Discuss Accelerated Approval Pathway for CardiAMP® System in Ischemic Heart Failure
02/04/2026
SUNNYVALE, Calif., April 02, 2026 (GLOBE NEWSWIRE) -- BioCardia ® , Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today [...]

Pages